ReviewMolecules (Basel, Switzerland)2021

LP1 and LP2: Dual-Target MOPr/DOPr Ligands as Drug Candidates for Persistent Pain Relief.

Lorella Pasquinucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.